🚀 Big news in the longevity game! NewLimit, co-founded by Coinbase's Brian Armstrong, just snagged a whopping $130 million in their Series B round, bringing their valuation to $810 million! 💰✨

Their mission? To turn back the clock on aging by reprogramming our genes and tweaking those pesky proteins in our cells. 🧬 The goal is to restore cellular function and help us all live longer, healthier lives!

So far, they've raised a grand total of $275 million—big shoutout to the investors like Kleiner Perkins and Khosla Ventures for believing in this vision! 🙌 #Longevity #HealthTech

[Read more here](https://t.co/iVbDMLQFNI)